The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Prevention of irinotecan-induced diarrhea by probiotics: Randomized double-blind, placebo-controlled phase III study.
Michal Mego
No relevant relationships to disclose
Jozef Chovanec
No relevant relationships to disclose
Iveta Andrezalova
No relevant relationships to disclose
Peter Konkolovsky
No relevant relationships to disclose
Milada Mikulova
No relevant relationships to disclose
Maria Reckova
No relevant relationships to disclose
Vera Miskovska
No relevant relationships to disclose
Branislav Bystricky
No relevant relationships to disclose
Lenka Medvecova
No relevant relationships to disclose
Dagmar Mikusova
No relevant relationships to disclose
Adela Lagin
No relevant relationships to disclose
Daniela Svetlovska
No relevant relationships to disclose
Stanislav Spanik
No relevant relationships to disclose
Jozef Mardiak
No relevant relationships to disclose
Vladimir Zajac
No relevant relationships to disclose
Lubos Drgona
No relevant relationships to disclose